Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00864110
What this trial is testing

Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Cell>Point LLC 4
Early research (Phase 1)Study completedNCT03974685
What this trial is testing

99mTc-3PRGD2 Injection in Healthy Volunteers

Who this might be right for
Healthy
RDO Pharm. 10
Early research (Phase 1)Study completedNCT00891241
What this trial is testing

Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

Who this might be right for
Heart Failure
Lantheus Medical Imaging 12
Early research (Phase 1)Study completedNCT05065541
What this trial is testing

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

Who this might be right for
Healthy Volunteers
Celgene 32
Very early researchLooking for participantsNCT07800481
What this trial is testing

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study)

Who this might be right for
Healthy AdultHealthy
Washington University School of Medicine 8
Early research (Phase 1)Study completedNCT00707499
What this trial is testing

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

Who this might be right for
Healthy
Lantheus Medical Imaging 13
Testing effectiveness (Phase 2)Study completedNCT00062894
What this trial is testing

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

Who this might be right for
Non-Hodgkin's Lymphoma
GlaxoSmithKline 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Early research (Phase 1)Active Not RecruitingNCT07681141
What this trial is testing

Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies

Who this might be right for
Patients With Advanced Metastatic FAP-Positive Tumors
First Affiliated Hospital of Fujian Medical University 3
Not applicableStudy completedNCT05537675
What this trial is testing

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction

Who this might be right for
Refractory Meningioma
Central Hospital, Nancy, France 20
Testing effectiveness (Phase 2)UnknownNCT05227482
What this trial is testing

Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres

Who this might be right for
HCC
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Not applicableUnknownNCT01521351
What this trial is testing

Natural History of Carotid Atherosclerosis

Who this might be right for
Carotid Artery DiseaseStrokeMyocardial Infarction+1 more
National and Kapodistrian University of Athens 700
Not applicableStudy completedNCT03580161
What this trial is testing

Simplification of Low Level Internal Dosimetry

Who this might be right for
Exposure to Medical Diagnostic Radiation
Royal Marsden NHS Foundation Trust 12
Very early researchEnded earlyNCT01583842
What this trial is testing

124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study

Who this might be right for
Neuroblastoma
Miguel Pampaloni 10
Not applicableUnknownNCT00749697
What this trial is testing

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

Who this might be right for
Thyroid CarcinomaMetastatic Sites Lung Bone Nodal
Royal Marsden NHS Foundation Trust 10
Testing effectiveness (Phase 2)Study completedNCT02931929
What this trial is testing

MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT

Who this might be right for
Gastrointestinal Stromal Tumors
Medical University Innsbruck 9
Early research (Phase 1)Not Yet RecruitingNCT07045428
What this trial is testing

68Ga-GP-01 Injection in Solid Tumors Participants

Who this might be right for
Solid Tumor Malignancies
GrandPharma (China) Co., Ltd. 20
Not applicableStudy completedNCT03297346
What this trial is testing

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer

Who this might be right for
Breast Cancer Female
French Nuclear Safety and Radiation Protection Authority (ASNR) 250
Very early researchLooking for participantsNCT07617688
What this trial is testing

Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers

Who this might be right for
Healthy Adult
MODAG GmbH 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06880757
What this trial is testing

177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Ankara University 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation